Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Department of Sociology, University of Oxford, Oxford, UK.
Psychol Med. 2024 Apr;54(6):1228-1234. doi: 10.1017/S0033291723003082. Epub 2023 Oct 20.
Previous research has proposed that there may be potential synergies between psychedelic and meditation interventions, but there are still knowledge gaps that merit further investigation.
Using a longitudinal observational research design with samples representative of the US and UK adult population with regard to sex, age, and ethnicity ( = 9732), we investigated potential associations between self-reported psychedelic use and meditation practice.
The follow-up survey was completed by 7667 respondents (79% retention rate), with 100 respondents reporting psychedelic use during the 2-month study period (1.3% of follow-up respondents). In covariate-adjusted regression models, psychedelic use during the study period was associated with greater increases in the number of days of mindfulness meditation practice in the past week ( = 0.40, = 0.004). Among those who reported psychedelic use during the study period, covariate-adjusted regression models revealed that the subjective experience of insight during respondents' most intense psychedelic experience in that period was also associated with greater increases in the number of days of mindfulness and loving-kindness or compassion meditation practice in the past week ( = 0.42, = 0.021; = 0.38, = 0.017). Notably, more days of loving-kindness or compassion meditation practice in the past week at baseline was associated with less severe subjective feelings of death or dying during respondents' most intense psychedelic experience in the study period ( = -0.29, = 0.037).
Psychedelic use might lead to greater engagement with meditation practices such as mindfulness meditation, while meditation practices such as loving-kindness or compassion medication might buffer against certain challenging experiences associated with psychedelic use.
先前的研究表明,迷幻药和冥想干预之间可能存在潜在的协同作用,但仍有一些知识空白需要进一步研究。
我们采用了纵向观察性研究设计,样本代表了美国和英国成年人在性别、年龄和种族方面的情况(n=9732),研究了自我报告的迷幻药使用与冥想练习之间的潜在关联。
在 2 个月的研究期间,有 100 名受访者报告使用了迷幻药(占随访受访者的 1.3%),完成了后续调查。在调整协变量的回归模型中,研究期间使用迷幻药与过去一周正念冥想练习天数的增加呈正相关(β=0.40,p=0.004)。在报告研究期间使用迷幻药的受访者中,调整协变量的回归模型显示,受访者在该期间最强烈的迷幻体验中体验到的洞察力与过去一周正念和慈悲冥想练习天数的增加呈正相关(β=0.42,p=0.021;β=0.38,p=0.017)。值得注意的是,过去一周慈悲冥想练习天数的增加与受访者在研究期间最强烈的迷幻体验中主观感受到的死亡或濒死感的严重程度呈负相关(β=-0.29,p=0.037)。
迷幻药的使用可能会导致更多人参与到正念冥想等冥想实践中,而慈悲冥想等冥想实践可能会减轻与迷幻药使用相关的某些挑战性体验。